Kalbe Farma Tbk PT
IDX:KLBF
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 400
1 750
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Kalbe Farma Tbk PT
Kalbe Farma Tbk PT
Total Equity
Kalbe Farma Tbk PT
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Total Equity
Rp21.8T
|
CAGR 3-Years
7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Total Equity
Rp8.4T
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
|
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
|
Total Equity
Rp1.5T
|
CAGR 3-Years
-1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Total Equity
Rp2.4T
|
CAGR 3-Years
3%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Total Equity
Rp1.2T
|
CAGR 3-Years
87%
|
CAGR 5-Years
58%
|
CAGR 10-Years
29%
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Total Equity
Rp5.3T
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
12%
|
|
Kalbe Farma Tbk PT
Glance View
PT Kalbe Farma Tbk engages in the development, distribution, and trading of pharmaceutical products. The company is headquartered in Jakarta, Dki Jakarta and currently employs 12,334 full-time employees. The firm provides healthcare solution through its four business divisions: the prescription pharmaceutical division, consumer health, nutritional, and distribution and logistics divisions. Its Prescription Pharmaceuticals division provides a range of products for all groups, from unbranded generic drugs for the mass-market segment, to branded generics and licensed drugs. The Consumer Health division's product portfolio spans from over-the-counter (OTC) drugs and energy drinks to a selection of ready-to-drink healthy beverage products. The Nutritional division manages a range of nutritional products, comprising of powdered milk products for all age segments: infants, toddlers, children, pre-teenagers, teenagers, adults, pregnant and lactating women. Its Distribution and Logistics Division operates the distribution coverage for pharmaceuticals products in Indonesia.
See Also
What is Kalbe Farma Tbk PT's Total Equity?
Total Equity
21.8T
IDR
Based on the financial report for Jun 30, 2024, Kalbe Farma Tbk PT's Total Equity amounts to 21.8T IDR.
What is Kalbe Farma Tbk PT's Total Equity growth rate?
Total Equity CAGR 10Y
10%
Over the last year, the Total Equity growth was 8%. The average annual Total Equity growth rates for Kalbe Farma Tbk PT have been 7% over the past three years , 8% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet
